Mizuho Asset Management Co. Ltd. boosted its stake in Cerner Corp. (NASDAQ:CERN) by 102.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,168 shares of the company’s stock after buying an additional 2,109 shares during the period. Mizuho Asset Management Co. Ltd.’s holdings in Cerner Corp. were worth $244,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the company. WASHINGTON TRUST Co raised its stake in Cerner Corp. by 5.9% in the first quarter. WASHINGTON TRUST Co now owns 315,798 shares of the company’s stock worth $16,724,000 after buying an additional 17,502 shares during the period. Pacad Investment Ltd. raised its position in shares of Cerner Corp. by 59.6% in the first quarter. Pacad Investment Ltd. now owns 23,646 shares of the company’s stock valued at $1,252,000 after buying an additional 8,834 shares during the last quarter. CIBC World Markets Inc. raised its position in shares of Cerner Corp. by 52.3% in the first quarter. CIBC World Markets Inc. now owns 10,000 shares of the company’s stock valued at $530,000 after buying an additional 3,434 shares during the last quarter. Badgley Phelps & Bell Inc. raised its position in shares of Cerner Corp. by 2.9% in the first quarter. Badgley Phelps & Bell Inc. now owns 145,700 shares of the company’s stock valued at $7,716,000 after buying an additional 4,055 shares during the last quarter. Finally, Virginia Retirement System acquired a new position in shares of Cerner Corp. during the first quarter valued at $4,019,000. Institutional investors own 81.38% of the company’s stock.

Cerner Corp. (NASDAQ:CERN) traded up 0.88% during trading on Tuesday, hitting $62.02. The company had a trading volume of 222,059 shares. The company’s 50 day moving average price is $64.64 and its 200-day moving average price is $58.32. Cerner Corp. has a 12 month low of $49.59 and a 12 month high of $68.31. The company has a market cap of $20.94 billion, a PE ratio of 34.06 and a beta of 0.66.

Cerner Corp. (NASDAQ:CERN) last announced its quarterly earnings results on Tuesday, August 2nd. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.57 by $0.01. Cerner Corp. had a net margin of 13.53% and a return on equity of 18.57%. The firm earned $1.22 billion during the quarter, compared to the consensus estimate of $1.21 billion. During the same period last year, the firm posted $0.52 EPS. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. Equities analysts expect that Cerner Corp. will post $2.36 earnings per share for the current year.

Several research analysts recently weighed in on the company. Canaccord Genuity reiterated a “buy” rating and issued a $68.00 price objective on shares of Cerner Corp. in a research report on Sunday, September 11th. Wells Fargo & Co. reiterated a “buy” rating on shares of Cerner Corp. in a research report on Sunday, June 26th. Piper Jaffray Cos. reiterated an “overweight” rating and issued a $81.00 price objective on shares of Cerner Corp. in a research report on Monday, August 29th. Jefferies Group reiterated a “buy” rating on shares of Cerner Corp. in a research report on Friday, June 10th. Finally, FBR & Co reiterated an “outperform” rating and issued a $73.00 price objective on shares of Cerner Corp. in a research report on Friday, June 3rd. Nine investment analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $66.18.

In other Cerner Corp. news, COO Michael Nill sold 50,000 shares of the firm’s stock in a transaction dated Monday, August 8th. The shares were sold at an average price of $67.16, for a total value of $3,358,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Michael R. Battaglioli sold 2,000 shares of the firm’s stock in a transaction dated Monday, August 8th. The shares were sold at an average price of $67.34, for a total transaction of $134,680.00. Following the completion of the sale, the vice president now owns 2,000 shares of the company’s stock, valued at approximately $134,680. The disclosure for this sale can be found here. Corporate insiders own 13.20% of the company’s stock.

About Cerner Corp.

Cerner Corporation is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations. Its segments include Domestic and Global. The Domestic segment includes the business activity in the United States.

5 Day Chart for NASDAQ:CERN

Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Corp. (NASDAQ:CERN).

Receive News & Ratings for Cerner Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.